Subunit-selective allosteric inhibition of glycine binding to NMDA receptors

Journal of Neuroscience

Volumn 32, Issue 18, 2012, Pages 6197-6208

  Hansen, Kasper B ^a   Ogden, Kevin K ^a   Traynelis, Stephen F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLORO 4 FLUORO N [(4 [(2 (PHENYLCARBONYL)HYDRAZINO)CARBONYL]PHENYL)METHYL] BENZENESULFONAMIDE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR SUBNUIT N1; GLUTAMATE RECEPTOR SUBNUIT N2; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TCN-201; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; XENOPUS;

ANIMALS; BINDING SITES; GLYCINE; HEK293 CELLS; HUMANS; PROTEIN BINDING; PROTEIN SUBUNITS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84860321928     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5757-11.2012     Document Type: Article

References (49)

1. Acker TM, Yuan H, Hansen KB, Vance KM, Ogden KK, Jensen HS, Burger PB, Mullasseril P, Snyder JP, Liotta DC, Traynelis SF (2011) Mechanism for noncompetitive inhibition by novel GluN2C/DN-methyl-D-aspartate receptor subunit-selective modulators. Mol Pharmacol 80:782-795.
2. Ahmed AH, Ptak CP, Oswald RE (2010) Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA. Biochemistry 49:2843-2850.
3. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48-58.
4. Benveniste M, Mienville JM, Sernagor E, Mayer ML (1990) Concentration-jump experiments with NMDA antagonistsinmouse cultured hippocam-pal neurons. J Neurophysiol 63:1373-1384.
5. Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM, Negri M, Andreetta F, Senar-Sancho SA, Guiral L, Cardullo F (2010) Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J Pharmacol Exp Ther 335:636-644.
6. Christopoulos A, Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54:323-374.
7. Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Skifter DA, Jane DE, Monaghan DT (2010) A novel family of negative and positive allo-steric modulators of NMDA receptors. J Pharmacol Exp Ther 335:614-621.
8. Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34:W116-W118.
9. Ehlert FJ (1988) Estimation of the affinities of allosteric ligands using radio-ligand binding and pharmacological null methods. Mol Pharmacol 33:187-194.
10. Furukawa H, Singh SK, Mancusso R, Gouaux E (2005) Subunit arrangement and function in NMDA receptors. Nature 438:185-192.
11. Gielen M, Le Goff A, Stroebel D, Johnson JW, Neyton J, Paoletti P (2008) Structural rearrangements of NR1/NR2A NMDA receptors during allo-steric inhibition. Neuron 57:80-93.
12. Gielen M, Siegler Retchless B, Mony L, Johnson JW, Paoletti P (2009) Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459:703-707.
13. Hald H, Ahring PK, Timmermann DB, Liljefors T, Gajhede M, Kastrup JS (2009) Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2. J Mol Biol 391:906-917.
14. Hansen KB, Traynelis SF (2011) Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J Neurosci 31:3650-3661.
15. Hansen KB, Naur P, Kurtkaya NL, Kristensen AS, Gajhede M, Kastrup JS, Traynelis SF (2009) Modulation of the dimer interface at ionotropic glutamate-like receptor 62 by D-serine and extracellular calcium. J Neurosci 29:907-917.
16. Hansen KB, Furukawa H, Traynelis SF (2010) Control of assembly and function of glutamate receptors by the amino-terminal domain. Mol Pharmacol 78:535-549.
17. Hedlund PB, Carson MJ, Sutcliffe JG, Thomas EA (1999) Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors. Biochem Pharmacol 58:1807-1813.
18. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843.
19. Jin R, Clark S, Weeks AM, Dudman JT, Gouaux E, Partin KM (2005) Mechanism of positive allosteric modulators acting on AMPA receptors. J Neurosci 25:9027-9036.
20. Kalia LV, Kalia SK, Salter MW (2008) NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol 7:742-755.
21. Kew JN, Trube G, Kemp JA (1996) A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 497:761-772.
22. Kew JN, Trube G, Kemp JA (1998) State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist. Br J Pharmacol 123:463-472.
23. Lazareno S, Birdsall NJ (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
24. McKay S, Griffiths NH, Butters PA, Thubron EB, Hardingham GE, Wyllie DJ (2011) Direct pharmacological monitoring of the developmental switch in NMDAR subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist. Br J Pharmacol. Advance online publication. Retrieved March 22, 2012. doi:10.1111/j.1476-5381.2011.01748.x.
25. Mony L, Kew JN, Gunthorpe MJ, Paoletti P (2009) Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol 157:1301-1317.
26. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burna-shev N, Sakmann B, Seeburg PH (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221.
27. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
28. Mosley CA, Acker TM, Hansen KB, Mullasseril P, Andersen KT, Le P, Vellano KM, Brauner-Osborne H, Liotta DC, Traynelis SF (2010) Quinazolin-4-one derivatives: a novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. J Med Chem 53:5476-5490.
29. Mullasseril P, Hansen KB, Vance KM, Ogden KK, Yuan H, Kurtkaya NL, Santangelo R, Orr AG, Le P, Vellano KM, Liotta DC, Traynelis SF (2010) A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nat Commun 1:90.
30. Naur P, Hansen KB, Kristensen AS, Dravid SM, Pickering DS, Olsen L, Vestergaard B, Egebjerg J, Gajhede M, Traynelis SF, Kastrup JS (2007) Ionotropic glutamate-like receptor delta2 binds D-serine and glycine. Proc Natl Acad Sci USA 104:14116-14121.
31. Ogden KK, Traynelis SF (2011) New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 32:726-733.
32. Plested AJ, Mayer ML (2007) Structure and mechanism of kainate receptor modulation by anions. Neuron 53:829-841.
33. Plested AJ, Vijayan R, Biggin PC, Mayer ML (2008) Molecular basis of kainate receptor modulation by sodium. Neuron 58:720-735.
34. Ptak CP, Ahmed AH, Oswald RE (2009) Probing the allosteric modulator binding site of GluR2 with thiazide derivatives. Biochemistry 48:8594-8602.
35. Schetz JA, Sibley DR (1997) Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors. J Neurochem 68:1990-1997.
36. Sun Y, Olson R, Horning M, Armstrong N, Mayer M, Gouaux E (2002) Mechanism of glutamate receptor desensitization. Nature 417:245-253.
37. Traynelis SF, Burgess MF, Zheng F, Lyuboslavsky P, Powers JL (1998) Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J Neurosci 18:6163-6175.
38. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405-496.
39. Ulbrich MH, Isacoff EY (2007) Subunit counting in membrane-bound proteins. Nat Methods 4:319-321.
40. Vance KM, Simorowski N, Traynelis SF, Furukawa H (2011) Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. Nat Commun 2:294.
41. Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB, Grayson DR (1998) Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J Neurophysiol 79:555-566.
42. Ward SE, Bax BD, Harries M (2010) Challenges for and current status of research into positive modulators of AMPA receptors. Br J Pharmacol 160:181-190.
43. Watanabe M, Inoue Y, Sakimura K, Mishina M (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3:1138-1140.
44. Williams K (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44:851-859.
45. Wong AY, Fay AM, Bowie D (2006) External ions are coactivators of kainate receptors. J Neurosci 26:5750-5755.
46. - dipole couples agonist binding to kainate receptor activation. J Neurosci 27:6800-6809.
47. Wyllie DJ, Chen PE (2007) Taking the time to study competitive antagonism. Br J Pharmacol 150:541-551.
48. Yuan H, Hansen KB, Vance KM, Ogden KK, Traynelis SF (2009) Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci 29:12045-12058.
49. Zhang XX, Bunney BS, Shi WX (2000) Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil. Synapse 37:56-63.